4//SEC Filing
OAKES FRANK R. 4
Accession 0001144204-18-053712
CIK 0001540159other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 9:49 PM ET
Size
5.1 KB
Accession
0001144204-18-053712
Insider Transaction Report
Form 4
OAKES FRANK R.
DirectorPresident, CEO & Director
Transactions
- Sale
Common Shares, without par value
2018-10-12$1.31/sh−3,000$3,930→ 51,924 total
Footnotes (2)
- [F1]These shares were sold pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001620188
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 9:49 PM ET
- Size
- 5.1 KB